JOHN MENDLEIN

Insider Reports History

Signature
/s/ Cindy Tahl, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by JOHN MENDLEIN:

Company Role Class Num Shares Value Price $ Report Date Ownership
FATE THERAPEUTICS INC Director Stock Option (Right to Buy) 55,000 $109,200 $2.73 29 May 2025 Direct
Omega Therapeutics, Inc. Director Stock Option (Right to Buy) 25,000 20 Jun 2024 Direct

Insider Reports Filed by JOHN MENDLEIN

Symbol Company Period Transactions Value $ Form Type Role Filing Time
FATE FATE THERAPEUTICS INC 29 May 2025 1 $0 4 Director 30 May 2025, 16:08
OMGA Omega Therapeutics, Inc. 20 Jun 2024 1 $0 4 Director 21 Jun 2024, 16:20
FATE FATE THERAPEUTICS INC 07 Jun 2024 1 $0 4 Director 11 Jun 2024, 16:27
OMGA Omega Therapeutics, Inc. 07 Jun 2023 1 $0 4 Director 09 Jun 2023, 16:05
FATE FATE THERAPEUTICS INC 06 Jun 2023 1 $0 4 Director 07 Jun 2023, 16:11
FATE FATE THERAPEUTICS INC 19 Jan 2023 2 +$38,992 4 Director 20 Jan 2023, 15:14
FATE FATE THERAPEUTICS INC 11 Jan 2023 2 +$698,138 4 Director 13 Jan 2023, 17:20
FATE FATE THERAPEUTICS INC 09 Jun 2022 2 $0 4 Director 13 Jun 2022, 16:42
OMGA Omega Therapeutics, Inc. 08 Jun 2022 1 $0 4 Director 10 Jun 2022, 16:10
FATE FATE THERAPEUTICS INC 03 Jun 2022 1 -$31,086 4 Director 06 Jun 2022, 16:49
FATE FATE THERAPEUTICS INC 10 Mar 2022 4 -$1,053,754 4 Director 11 Mar 2022, 15:58
OMGA Omega Therapeutics, Inc. 29 Jul 2021 0 $0 3 Director 29 Jul 2021, 21:04
FATE FATE THERAPEUTICS INC 02 Jun 2021 2 $0 4 Director 04 Jun 2021, 17:24